Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT01654250
Brief Summary:
The safety and efficacy of a chewable formulation of extended-release methylphenidate will be studied in children with ADHD
Study:
NCT01654250
Study Brief:
Protocol Section:
NCT01654250